Skip to main content

Table 3 Percent change, 95% confidence intervals of percent change depression treatment categories (Reference Group = No Depression Treatment) multiple linear regressions of log-transformed dollars (2005 $), medicare current beneficiary survey, 2000 – 2005

From: Depression treatment and short-term healthcare expenditures among elderly Medicare beneficiaries with chronic physical conditions

Expenditures Antidepressants only Psych Tx (with or w/o AD)
  % Change 95% CI p-value % Change 95% CI p-value
Total 20.2 [14.1 , 26.7] <0.001 29.4 [18.8 , 41.0] <0.001
Inpatient 31.4 [7.5 , 60.7] 0.008 56.9 [7.2 , 129.5] 0.021
Outpatient 11.1 [-2.4 , 26.3] 0.112 28.1 [ 0.0 , 64.2] 0.051
Medical provider 17.6 [12.1 , 23.5] <0.001 28.6 [18.7 , 39.3] <0.001
Prescription drug 26.8 [18.9 , 35.2] <0.001 31.2 [20.2 , 43.2] <0.001
Other -6.8 [-20.6, 9.4] 0.389 13.5 [-15.2 , 51.9] 0.396
  1. Note: Based on 1,055 community-dwelling elderly aged 65 years or older, and followed for one year during 2001 through 2005. Expenditures were measured in the follow-up year and depression treatment was measured in the baseline year.
  2. Percent changes of healthcare expenditures for depression treatment categories were calculated from parameter estimates from separate regressions on total, inpatient, outpatient, medical provider, prescription drugs, and other expenditures which included dental, vision, and durable medical equipment. The models adjusted for other independent variables: predisposing (gender, race, age, year of observation), enabling (marital status, education, poverty status, prescription drug coverage), need (health status, functional status), personal health practices (smoking status, body mass index), healthcare use (baseline year log-transformed expenditures), and external environment (metro status) factors.
  3. Tx: Treatment; AD: Antidepressants; Psych Tx(with or w/o AD): Psychotherapy with or without antidepressants.